174 related articles for article (PubMed ID: 36530960)
1. A Rare Case of MDA-5-Positive Amyopathic Dermatomyositis with Rapidly Progressive Interstitial Lung Disease Following COVID-19 mRNA Vaccination - a Case Report.
Wang S; Noumi B; Malik F; Wang S
SN Compr Clin Med; 2023; 5(1):18. PubMed ID: 36530960
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report.
Cao M; Zhang S; Chu D; Xiao M; Liu X; Yu L; Li J; Huang Y; Fang F
BMC Pulm Med; 2020 Nov; 20(1):304. PubMed ID: 33213393
[TBL] [Abstract][Full Text] [Related]
3. Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review.
McPherson M; Economidou S; Liampas A; Zis P; Parperis K
Semin Arthritis Rheum; 2022 Apr; 53():151959. PubMed ID: 35134633
[TBL] [Abstract][Full Text] [Related]
4. Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review.
Nishi K; Ogura M; Tamai N; Gima M; Ide K; Koinuma G; Kamei K; Ito S
Pediatr Rheumatol Online J; 2022 Aug; 20(1):60. PubMed ID: 35927666
[TBL] [Abstract][Full Text] [Related]
5. Respiratory symptoms as initial manifestations of interstitial lung disease in clinically amyopathic juvenile dermatomyositis: a case report with literature review.
Xia J; Jiang G; Jin T; Shen Q; Ma Y; Wang L; Qian L
BMC Pediatr; 2021 Nov; 21(1):488. PubMed ID: 34732158
[TBL] [Abstract][Full Text] [Related]
6. [Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: an atypical case].
Girard C; Vincent T; Bessis D
Ann Dermatol Venereol; 2013 Oct; 140(10):628-34. PubMed ID: 24090894
[TBL] [Abstract][Full Text] [Related]
7. MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report.
Alqatari S; Riddell P; Harney S; Henry M; Murphy G
BMC Pulm Med; 2018 Apr; 18(1):59. PubMed ID: 29665800
[TBL] [Abstract][Full Text] [Related]
8. Rapidly progressive interstitial lung disease due to anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis complicated with cervical cancer: Successful treatment with direct hemoperfusion using polymyxin B-immobilized fiber column therapy.
Ichiyasu H; Sakamoto Y; Yoshida C; Sakamoto K; Fujita R; Nakayama G; Okabayashi H; Saeki S; Okamoto S; Kohrogi H
Respir Med Case Rep; 2017; 20():51-54. PubMed ID: 27995057
[TBL] [Abstract][Full Text] [Related]
9. MDA-5 dermatomyositis complicated by interstitial lung disease and cutaneous ulcers: successful treatment with corticosteroids, mycophenolate mofetil and intravenous immunoglobulin.
Stager K; Wise L
BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32998908
[TBL] [Abstract][Full Text] [Related]
10. Progressive interstitial lung disease in hypomyopathic dermatomyositis in the COVID-19 pandemic: A case report.
Wang S; Lyu Y; Xu L; Zhang W
Int J Rheum Dis; 2023 Apr; 26(4):759-763. PubMed ID: 36502514
[TBL] [Abstract][Full Text] [Related]
11. Dermatomyositis Flare-Up Following the SARS-CoV-2 Vaccine: A Case Report and Literature Review.
Ryad R; Osman A; Almusa A; Gerges P; Sumbul-Yuksel B
Cureus; 2023 Aug; 15(8):e44324. PubMed ID: 37779754
[TBL] [Abstract][Full Text] [Related]
12. Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review.
Yeung TW; Cheong KN; Lau YL; Tse KN
Pediatr Rheumatol Online J; 2021 Jun; 19(1):103. PubMed ID: 34193210
[TBL] [Abstract][Full Text] [Related]
13. Anti-MDA5 Associated Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Lung Disease.
Tavakolian K; Odak M; Mararenko A; Ilagan J; Douedi S; Khan T; Al Saoudi G
J Med Cases; 2022 Aug; 13(8):374-379. PubMed ID: 36128070
[TBL] [Abstract][Full Text] [Related]
14. Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis.
So H; Wong VTL; Lao VWN; Pang HT; Yip RML
Clin Rheumatol; 2018 Jul; 37(7):1983-1989. PubMed ID: 29713969
[TBL] [Abstract][Full Text] [Related]
15. Double anti-PL-7 and anti-MDA-5 positive Amyopathic Dermatomyositis with rapidly progressive interstitial lung disease in a Hispanic patient.
Li ZY; Gill E; Mo F; Reyes C
BMC Pulm Med; 2020 Aug; 20(1):220. PubMed ID: 32799827
[TBL] [Abstract][Full Text] [Related]
16. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis.
Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
Arthritis Care Res (Hoboken); 2016 May; 68(5):689-94. PubMed ID: 26414240
[TBL] [Abstract][Full Text] [Related]
17. Amyopathic Dermatomyositis Associated with Histopathological Findings of Organizing Pneumonia and Pulmonary Vasculitis.
Lim JU; Kang HS; Kim YH; Kim TJ
Balkan Med J; 2017 Aug; 34(4):374-377. PubMed ID: 28443580
[TBL] [Abstract][Full Text] [Related]
18. Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report.
Kishi T; Tani Y; Okiyama N; Mizuochi K; Ichimura Y; Harigai M; Nagata S; Miyamae T
Pediatr Rheumatol Online J; 2021 Mar; 19(1):34. PubMed ID: 33740993
[TBL] [Abstract][Full Text] [Related]
19. Hypomyopathic dermatomyositis associated with interstitial lung disease and good response to mycophenolate mofetil: case-based review.
Koyama RVL; Braga TKK; da Silva Dias GA; Fujihara S; Fuzii HT; Yoshikawa GT
Clin Rheumatol; 2017 Aug; 36(8):1919-1926. PubMed ID: 28488124
[TBL] [Abstract][Full Text] [Related]
20. Dermatomyositis Following BNT162b2 mRNA COVID-19 Vaccination.
Gouda W; Albasri A; Alsaqabi F; Al Sabah HY; Alkandari M; Abdelnaby H
J Korean Med Sci; 2022 Feb; 37(5):e32. PubMed ID: 35132838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
